← Leaderboards
Denise M Inman
Northeast Ohio Medical University
$4,167,012
Attributed
$4,167,012
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $629.9K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,167,012 · 2
By mechanism
R01$3,784,926 · 1
R21$382,086 · 1
Top collaborators
No co-investigators on record.
Most similar at Northeast Ohio Medical University
Same institution · by research overlap
- Yanqiao Zhang$17,285,691
- Fayez F Safadi$5,848,966
- Liya Yin$7,447,549
- Yong Lu$3,922,797
- Erin G Reed-Geaghan$1,766,660
Others in their field
Top investigators on “Retinal Ganglion Cells”
- David R Williams · University Of Rochester$21,735,700
- David Huang · Cleveland Clinic Lerner Col/Med-Cwru$21,143,307
- Cecilia Sungmin Lee · University Of Washington$17,197,690
- Joshua R Sanes · Washington University$17,158,387
- Dennis Michael Dacey · University Of Washington$16,958,250
- Eduardo J Chichilnisky · Stanford University$16,093,921
Research focus
Retinal Ganglion CellsPhysiologic Intraocular PressureCellsGlaucomaPathologyPublic HealthMetabolicNeurogliaMitochondrial DysfunctionNew Therapeutic TargetFunctional DisorderMitochondriaAnimalsMouse ModelPositioning AttributeInsightOptic NerveHigh Intraocular PressureBioenergeticsInnovationPhysiologicalChronicAxonal DegenerationRecycling
Grant awards (14)
Metabolic Vulnerability as a Diseased Target for Glaucoma$372,295
R01 · FY2025 · EY · contact PI
Optic nerve head metabolic change promotes fibrosis$190,991
R21 · FY2025 · EY · contact PI
Metabolic Vulnerability as a Diseased Target for Glaucoma$372,295
R01 · FY2024 · EY · contact PI
Optic nerve head metabolic change promotes fibrosis$191,095
R21 · FY2024 · EY · contact PI
Metabolic Vulnerability as a Diseased Target for Glaucoma$57,439
R01 · FY2024 · EY · contact PI
Metabolic Vulnerability as a Diseased Target for Glaucoma$9,081
R01 · FY2024 · EY · contact PI
Metabolic Vulnerability as a Diseased Target for Glaucoma$372,295
R01 · FY2023 · EY · contact PI
Metabolic Vulnerability as a Diseased Target for Glaucoma$361,126
R01 · FY2022 · EY · contact PI
Metabolic Vulnerability as a Diseased Target for Glaucoma$372,295
R01 · FY2021 · EY · contact PI
Metabolic vulnerability as a disease target for glaucoma$365,000
R01 · FY2020 · EY · contact PI
Metabolic vulnerability as a disease target for glaucoma$379,000
R01 · FY2019 · EY · contact PI
Metabolic vulnerability as a disease target for glaucoma$379,000
R01 · FY2018 · EY · contact PI
Metabolic vulnerability as a disease target for glaucoma$379,000
R01 · FY2017 · EY · contact PI
Metabolic vulnerability as a disease target for glaucoma$366,100
R01 · FY2016 · EY · contact PI